David Matthew T
SEC CIK 1811612 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRMD | CorMedix Inc. | CFO, Interim CEO | 95.3K | $14.1K | — | 8 | 2021-11-17 | 2025-01-10 |
Most active insiders at CRMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dillione Janet | Dir | — | $1.55M |
| 2 | Lefkowitz Steven W | Dir | — | $475.2K |
| 3 | Todisco Joseph | CEO, Dir | — | $360.0K |
| 4 | Kaplan Myron | Dir | $275.5K | — |
| 5 | DUNTON ALAN W | Dir | — | $260.0K |
| 6 | Seckler Michael David | Chief Commercial Off | — | — |
| 7 | Zelnick Kaufman Beth | CLO | — | — |
| 8 | Duncan Gregory Scott | Dir | — | — |
| 9 | Blum Susan | CFO | — | — |
| 10 | Hurlburt Elizabeth | COO | — | — |
David Matthew T made no open-market trades at CRMD in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | 2025-01-10 | CRMD | CorMedix Inc. | David Matthew T | CFO | F - Tax | $11.19 | -6,515 | 95.3K | -6% | -$72.9K | |
| 2025-01-06 | 2025-01-02 | CRMD | CorMedix Inc. | David Matthew T | CFO | A - Grant | $0.00 | +62.5K | 110.4K | +130% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | CorMedix Inc. | David Matthew T | CFO | F - Tax | $8.22 | -8,648 | 101.8K | -8% | -$71.1K | |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | David Matthew T | CFO | F - Tax | $3.47 | -5,216 | 47.9K | -10% | -$18.1K |
| D | 2024-01-17 | 2024-01-12 | CRMD | CorMedix Inc. | David Matthew T | CFO | A - Grant | $0.00 | +50.0K | 53.1K | +1,587% | $0 |
| 2021-12-07 | 2021-12-06 | CRMD | CorMedix Inc. | David Matthew T | CFO, Interim CEO | P - Purchase | $4.50 | +1,000 | 3,150 | +47% | +$4,500 | |
| 2021-12-07 | 2021-12-06 | CRMD | CorMedix Inc. | David Matthew T | CFO, Interim CEO | P - Purchase | $4.50 | +1,000 | 3,150 | +47% | +$4,500 | |
| 2021-11-19 | 2021-11-17 | CRMD | CorMedix Inc. | David Matthew T | CFO, Interim CEO | P - Purchase | $5.07 | +1,000 | 2,150 | +87% | +$5,070 |
Purchase Sale Sale after option exercise All abbreviations